Companion Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.70 M
- Revenue Growth -8.57%
- Profit Growth -5.06%
- Ebitda -48.68%
- Net Worth 28.33%
- Total Assets 25.75%
About Companion Pharmaceuticals
Companion Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 January 2014 and has a history of 11 years and one month. Its registered office is in Bagalkot, Karnataka, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Companion Pharmaceuticals Private Limited India is Anandkumar Badiger as CEO. Bhimappa Santi and Chetan Hosur serve as directors at the Company.
Company Details
- Location
Bagalkot, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230KA2014PTC073212
- Company No.
073212
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Companion Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anandkumar Badiger | CEO | 28-Oct-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhimappa Santi  | Director | 23-Feb-2022 | Current |
| Chetan Hosur | Director | 23-Feb-2022 | Current |
Financial Performance of Companion Pharmaceuticals.
Companion Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.57% decrease. The company also saw a slight decrease in profitability, with a 5.06% decrease in profit. The company's net worth Soared by an impressive increase of 28.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Companion Pharmaceuticals?
In 2017, Companion Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹2.70 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2021 | Hdfc Bank Limited | ₹2.70 M | Satisfied |
How Many Employees Work at Companion Pharmaceuticals?
Unlock and access historical data on people associated with Companion Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Companion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Companion Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
